W STRATEGIES, LLC

Lobbying for INCYTE CORPORATION · â€‹Biopharmaceutical Company.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Delaware

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

Lobbying activity 2

Health Issues

Education around access to innovative therapies in dermatology. Issues related to the 340(b)program.

Medicare/Medicaid

Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.